Hudson Bay Capital Management LP Intercept Pharmaceuticals, Inc. Transaction History

Hudson Bay Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$46.7 - $92.04 $2.34 Million - $4.6 Million	-50,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$48.35 - $118.68 $2.42 Million - $5.93 Million	50,000 New	50,000 $3.15 Million
Q4 2019 Feb 12, 2020	SELL	$57.36 - $124.1 $1.72 Million - $3.72 Million	-30,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $2.33 Million - $3.62 Million	30,000 New	30,000 $2.39 Million
Q1 2018 May 14, 2018	SELL	$52.72 - $67.25 $1.58 Million - $2.02 Million	-30,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$58.2 - $72.76 $1.75 Million - $2.18 Million	30,000	30,000 $1.75 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.